evidence: The past few years saw the coronavirus ravaging the world, resulting in a staggering and tragic number of deaths. Fortunately, drugs such as Actemra and an anti-interleukin-1biologic called Anakinra, the former developed by Dr. Tadamitsu Kishimoto and the later by Dr. Charles Dinarello, both the 2020 Tang Prize laureates in Biopharmaceutical Science, have been approved by America’s Food and Drug Administration (US FDA) and the European Medicines Agency (EMA) to treat COVID-19. A CRISPR-based Sars-Cov-2 rapid test kit developed in the lab of Dr. Feng Zhang, recipient of the 2016 Tang Prize in Biopharmaceutical Science, has also been given the green light by the US FDA and EMA two years ago for general use.